ATLASTeva Pharmaceutical Industries (TEVA) earnings date: Nov 3, 2026
Teva Pharmaceutical Industries (TEVA) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, before the open. Analysts expect EPS of $0.70.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TEVA
| Last price | $42.09 (+1.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.9% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Teva Pharmaceutical Industries stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Teva Pharmaceutical Industries reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Teva Pharmaceutical Industries. You can switch it off at any time.
Alert me before TEVA reportsFree to start. Creating an account takes under a minute.
TEVA earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.70 |
| Last report | Jul 29, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -8.5% |
| Average move around a report | ±10.9% (last 4) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Teva Pharmaceutical Industries earnings history: last 4 reports
Teva Pharmaceutical Industries last reported on Jul 29, 2026: EPS of $0.02 against an estimate of $0.11 (-81.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 29, 2026 | $0.11 | $0.02 | -81.8% | Miss | +11.8% |
| Apr 29, 2026 | $0.46 | $0.53 | +15.2% | Beat | +10.9% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | +1.5% |
| Nov 5, 2025 | $0.67 | $0.78 | +16.4% | Beat | +19.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TEVA
See the fair value, the probability range and the earnings history of Teva Pharmaceutical Industries on its ATLAS page.
Teva Pharmaceutical Industries (TEVA) stock analysisPlans from €3.99 a month.
Teva Pharmaceutical Industries earnings: frequently asked questions
When does Teva Pharmaceutical Industries (TEVA) report earnings?
Teva Pharmaceutical Industries is scheduled to report on Tuesday, November 3, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TEVA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.70 per share (USD). Estimates can change before the report.
How often does TEVA beat earnings estimates?
Of its last 4 reports with a recorded result, Teva Pharmaceutical Industries beat the EPS estimate 3 times; the average surprise was -8.5%. Past results do not predict the next one.
How much does TEVA move around earnings?
Over its last 4 reports the stock moved an average of 10.9% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Teva Pharmaceutical Industries beat earnings estimates last quarter?
Teva Pharmaceutical Industries last reported on Jul 29, 2026: EPS of $0.02 against an estimate of $0.11 (-81.8% surprise), a miss.
How much does TEVA usually move in a day?
On a normal trading day the ATLAS model puts TEVA’s one-day range at about ±1.9%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer